Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type |
Focus Area
Sort descending
|
Country |
Application Due Date |
|---|---|---|---|---|
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
|
Quality Improvement | Oncology | Canada | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Canada | |
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA |
| Title |
Grant Type |
Focus Area
Sort descending
|
Country |
Application Due Date |
|---|---|---|---|---|
Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis
Release Date:
|
||||
Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe Program
Release Date:
|
||||
Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
Release Date:
|
||||
Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
Release Date:
|
||||
Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
Release Date:
|
||||
Pediatric Immunization Series Completion
Release Date:
|
||||
Facilitation of the Diagnosis of Rheumatoid Arthritis
Release Date:
|
||||
Pfizer and NCCN: Metastatic Breast Cancer
Release Date:
|
||||
Improving Care of Chronic Pain- Physician Groups and Health Systems
Release Date:
|
||||
Achievement of Treat-to-Target in Rheumatoid Arthritis
Release Date:
|
||||
Anticoagulation Education - NVAF or VTE
Release Date:
|
||||
Transition of Care in VTE
Release Date:
|